Personalis Says Study Shows NeXT Personal Test's 'High Sensitivity' for Lung Cancer Detection
Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $9
Personalis and UK Scientists Publish Study on Lung Cancer Detection Using CtDNA in Nature Medicine
New Nature Medicine Publication Shows CtDNA Levels Linked to Recurrence Risk in Lung Cancer
Personalis (NASDAQ:PSNL) Pulls Back 16% This Week, but Still Delivers Shareholders Impressive 222% Return Over 1 Year
A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $8 to $11
104763317 : how about litm
Jaguar8 OP 104763317 : Can’t you read?
Yi xun Wei 152530786 : This company must be giving you a lot of money, otherwise why would you keep recommending its stocks.
Jaguar8 OP Yi xun Wei : Likely he is bag holding![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Yi xun Wei 152530786 : It's almost suspended, stop promoting it! Let's see if your stock can rise.
View more comments...